| Vial description: |
HL9, ILT5, LIR3, LIR-3 |
| Category: |
control peptide |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
pure |
| Reactivity: |
not determined |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
O75022 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
, Freeze thaw will destroy a percentage in every cycle and should be avoided, Isotype or positive controls by peptides, Peptides short amino acid chains or epitopes or blocking antagonists, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, antibodies and deactivated samples, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
CD85a / LILRB3 peptide |
| Short name: |
anti-CD85a / LILRB3 control peptide Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, peptides, Antibody |
| Alternative name: |
member 3 reference short protein sequence (Antibody to), subfamily B (including TM and ITIM domains), antibody to-CD85a / leukocyte immunoglobulin-like receptor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
LILRB3 and IDBG-68373 and ENSG00000204577 and 102724997, Plasma membranes, member 3, protein binding, subfamily B (with TM and ITIM domains), this GO :0002376 and immune system process and biological process this GO :0004872 and receptor activity and molecular function this GO :0004888 and transmembrane signaling receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006952 and defense response and biological process this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0045087 and innate immune response and biological process this GO :0045671 and negative regulation of osteoclast differentiation and biological process, this GO :0004872 : receptor activity, this GO :0004872 : receptor activity and also this GO :0004888 : transmembrane signaling receptor activity and also this GO :0005515 : protein binding, this GO :0004888 : transmembrane signaling receptor activity, this GO :0005515 : protein binding, 11025, 102725015, 102725027, 102725029, 102725031, 102725034, 102725035, 102725273, leukocyte immunoglobulin-like receptor |
| Identity: |
6607 |
| Gene: |
LILRB3 |
More about : LILRB3 |
| Long gene name: |
leukocyte immunoglobulin like receptor B3 |
| Synonyms gene name: |
leukocyte immunoglobulin-like receptor, member 3 , subfamily B (with TM and ITIM domains) |
| Synonyms: |
LIR-3 HL9 ILT5 LIR3 CD85a PIRB PIR-B |
| Synonyms name: |
leucocyte Ig-like receptor B3 |
| Locus: |
19q13, 42 |
| Discovery year: |
2000-01-11 |
| GenBank acession: |
U91928 |
| Entrez gene record: |
11025 |
| Pubmed identfication: |
9278324 9382880 |
| RefSeq identity: |
NM_006864 |
| Classification: |
Inhibitory leukocyte immunoglobulin like receptors CD molecules |
| Havana BLAST/BLAT: |
OTTHUMG00000066626 |